Thursday 25th May
10am EDT / 3pm BST / 4pm CEST
With women accounting for half of the international inhabitants, women’s healthcare is a vital market for the pharmaceutical business.When desirous about women’s health, we have a tendency to consider illnesses that are linked particularly to feminine biology. However, it is very important not over-simplify this definition; women’s healthcare additionally consists of illnesses that are extra prevalent in women and health buying behaviour which is extra widespread amongst females (e.g. aesthetic remedy), all of which current large alternatives for the pharma business.
Furthermore regardless of persistent gender wage gaps, women globally earn and personal greater than ever earlier than and are anticipated to regulate almost 75 % of discretionary spending worldwide by 2028.In emerging markets, the women’s health area can also be deeply influenced by gender roles and societal attitudes to intercourse and copy. It is extraordinarily dynamic from a worldwide perspective; as such, the opportunity for women’s health varies extensively from one nation to a different. An understanding of this and the related challenges is prime when defining and establishing the opportunity for pharmaceutical corporations in this space.
Join market analysis consultants Sue Rees and Helen Mace for this complimentary webinar in which they may discover the opportunity for women’s health in emerging markets. They will talk about why understanding and enhancing women’s health in emerging markets may be difficult and the way market analysis can be utilized to perceive behaviours and attitudes to totally different women’s health issues. Finally they’ll define what methods international pharma can develop to help women and overcome these challenges.
Register right here: http://bit.ly/2qmcGae
Key areas that might be mentioned in the webinar embrace:
An overview of women’s health
A abstract of what women’s health means in emerging markets and key environmental influences e.g. societal pressures, gender / cultural norms and monetary useful resource.
Areas of opportunity for pharma
Specific examples in the context of fertility, aesthetics and sexual dysfunction shall be referenced to spotlight the vital opportunity for pharma /healthcare.
Research challenges and issues
in order to conduct profitable analysis and really maximise the opportunity for pharma / healthcare, we’ll speak by means of challenges related to women’s health in emerging markets and talk about what might be carried out to beat / ease these.
If you’re unable to attend, however want to view the recording, register for free and we’ll ship you a weblink. Or, if you need to seek out out extra about our analysis capabilities in emerging markets or expertise in women’s health, please be happy to contact us.